BRAF and neoplasm: This is accompanied by an early mutation of the BRAF oncogene [6], [7], and acquisition of the CpG Island Methylator Phenotype (CIMP) which involves widespread promoter hypermethylation and subsequent silencing of key tumour suppressor genes [8], [9].